BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 8841318)

  • 1. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.
    Deschiens MA; Conard J; Horellou MH; Ameri A; Preter M; Chedru F; Samama MM; Bousser MG
    Stroke; 1996 Oct; 27(10):1724-30. PubMed ID: 8841318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden mutation in cerebral venous thrombosis.
    Zuber M; Toulon P; Marnet L; Mas JL
    Stroke; 1996 Oct; 27(10):1721-3. PubMed ID: 8841317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
    Martinelli I; Mannucci PM; De Stefano V; Taioli E; Rossi V; Crosti F; Paciaroni K; Leone G; Faioni EM
    Blood; 1998 Oct; 92(7):2353-8. PubMed ID: 9746774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
    Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis.
    Uthman I; Khalil I; Sawaya R; Taher A
    Clin Rheumatol; 2004 Aug; 23(4):362-3. PubMed ID: 15293102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.
    Weih M; Vetter B; Ziemer S; Mehraein S; Valdueza JM; Koscielny J; Kulozik AE; Einhäupl KM
    J Neurol; 1998 Mar; 245(3):149-52. PubMed ID: 9553844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis.
    Tufano A; Guida A; Coppola A; Nardo A; Di Capua M; Quintavalle G; Di Minno MN; Cerbone AM; Di Minno G
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s337-42. PubMed ID: 23399370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers.
    Grossman D; Heald PW; Wang C; Rinder HM
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):409-13. PubMed ID: 9308555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders.
    Jensen MK; de Nully Brown P; Thorsen S; Hasselbalch HC
    Am J Hematol; 2002 Mar; 69(3):185-91. PubMed ID: 11891805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilia and cerebral vein thrombosis.
    Iorio A; Barnes C; Vedovati MC; Favaloro EJ
    Front Neurol Neurosci; 2008; 23():55-76. PubMed ID: 18004053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral venous thrombosis and anticardiolipin antibodies.
    Carhuapoma JR; Mitsias P; Levine SR
    Stroke; 1997 Dec; 28(12):2363-9. PubMed ID: 9412615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Leiden mutation of coagulation factor V in Hungarian SLE patients.
    Regéczy N; Lakos G; Balogh I; Ajzner E; Kiss E; Szegedi G
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):41-5. PubMed ID: 10726048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.
    Egesel T; Büyükasik Y; Dündar SV; Gürgey A; Kirazli S; Bayraktar Y
    J Clin Gastroenterol; 2000 Jan; 30(1):66-71. PubMed ID: 10636214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of venous thrombosis in fifty Chinese patients.
    Ho CH; Chau WK; Hsu HC; Gau JP; Yu TJ
    Am J Hematol; 2000 Feb; 63(2):74-8. PubMed ID: 10629572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary thrombophilia in cerebral venous thrombosis: a study from India.
    Pai N; Ghosh K; Shetty S
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):540-3. PubMed ID: 23518830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.
    Beye A; Pindur G
    Clin Hemorheol Microcirc; 2017; 67(3-4):261-266. PubMed ID: 28869458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral venous thrombosis and activated protein C resistance.
    Dulli DA; Luzzio CC; Williams EC; Schutta HS
    Stroke; 1996 Oct; 27(10):1731-3. PubMed ID: 8841319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute superior mesenteric vein thrombosis associated with factor V 'Leiden' gene mutation.
    Shah SR; Gupta AD; Sharma A; Joshi A; Desai D; Abraham P
    J Assoc Physicians India; 2003 Jun; 51():611-3. PubMed ID: 15266932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.